Musculoskeletal Oncology Hub

Board-reviewed management of benign and malignant bone and soft tissue tumors. Our approach focuses on margin-controlled excision and complex segmental reconstruction.

Program Volume 450+

Surgical Precision Zero-Margin

Core Integration Custom Segmental

Consult Program Coordinator

Program Leadership

Primary Faculty

Dr. Nitish Bhan Lead – Oncological Reconstruction

Dr. Prashanth Reddy A Senior Trauma Consultant

Board Governance

Multidisciplinary Tumor Board External Ethics & Pathology Board

Dr. Deepthi Nandan Reddy (HOD) Institutional Governance

Program Strategy: Zero-margin resection combined with durable segmental limb salvage utilizing custom implantology or structural grafting.

Institutional Selection Protocol

Suspected bone or soft tissue mass

Known primary bone malignancies (Osteosarcoma, Ewing's)

Benign aggressive tumors requiring reconstruction

Metastatic bone disease requiring stabilization

Technical Infrastructure

Navigation Margin Control

Precision excision mapping.

Custom Segmental Implants

Patient-specific limb salvage.

Technical Execution

Program Procedure Spokes

Technical documentation for surgical procedures governed by this program protocol.

Bone Tumor Excision

Institutional Technical Spoke

Limb Salvage Reconstruction

Institutional Technical Spoke

Referral & Case Governance

All cases within the Musculoskeletal Oncology Hub are reviewed by the Precision Surgical Board to ensure alignment with our multi-fellowship clinical benchmarks.

Speak with Program Lead